業務
貨幣單位:美元
2024/Q3
名稱營收比例
Human immunodeficiency virus (HIV)1,834.7萬45.97%
Molecular Sample Management Solutions1,280.6萬32.08%
Hepatitis C virus (HCV)322.8萬8.09%
Coronavirus disease 2019 (COVID-19)215.5萬5.40%
Risk assessment testing191.1萬4.79%
Other product and service revenues119.6萬3.00%
Non-product and services revenues26.3萬0.66%
Molecular Services9,0000.02%
查看全部
地區
貨幣單位:美元
2023/FY
名稱營收比例
美國3.62億89.19%
其他地區3,570.1萬8.80%
歐洲811.1萬2.00%
